Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Март 21, 2025
Heart
aging
involves
a
complex
interplay
of
genetic
and
environmental
influences,
leading
to
gradual
deterioration
cardiovascular
integrity
function.
Age-related
physiological
changes,
including
ventricular
hypertrophy,
diastolic
dysfunction,
myocardial
fibrosis,
increased
arterial
stiffness,
endothelial
are
influenced
by
key
mechanisms
like
autophagy,
inflammation,
oxidative
stress.
This
review
aims
explore
the
therapeutic
potential
plant-derived
bioactive
antioxidants
in
mitigating
heart
aging.
These
compounds,
often
rich
polyphenols,
flavonoids,
other
phytochemicals,
exhibit
notable
antioxidant,
anti-inflammatory,
cardioprotective
properties.
substances
have
intricate
properties,
ability
scavenge
ROS,
enhance
endogenous
antioxidant
defenses,
regulate
signaling
pathways,
impede
fibrosis
inflammation-promoting
processes.
By
focusing
on
molecular
linked
cardiac
aging,
produced
from
plants
provide
significant
promise
reduce
age-related
decline
improve
general
health.
Through
comprehensive
analysis
preclinical
clinical
studies,
this
work
highlights
associated
with
promising
effects
antioxidants.
The
findings
may
helpful
for
researchers
identifying
specific
molecules
preventive
heart.
Inflammopharmacology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 9, 2025
Abstract
Objective
This
study
aimed
to
assess
the
potential
antifibrotic
impact
of
zinc
sulfate
in
chronic
Hepatitis
C
Virus
(HCV)
patients
receiving
direct-acting
antiviral
therapy.
Methods
randomized
controlled
included
50
HCV-infected
with
fibrosis
stage
(F1
&
F2).
Participants
were
randomly
assigned
two
groups:
Group
1
(Control
group,
n
=
25)
received
standard
therapy
for
3
months,
while
2
(Zinc
mg/day
addition
same
duration.
Baseline
and
3-month
post-intervention
assessments
evaluating
serum
levels
hyaluronic
acid,
transforming
growth
factor
beta-1,
fibronectin.
Furthermore,
indices
liver
fibrosis,
such
as
Fibrosis
Index
based
on
4
factors
(FIB-4)
Aspartate
Transaminase-to-Platelet-Ratio
(APRI),
calculated
during
these
assessments.
Results
At
baseline,
studied
groups
had
no
statistical
difference
demographic
laboratory
data.
After
treatment,
significantly
increased
zinc-treated
group
compared
control
group.
Additionally,
fibronectin
acid
reduced
(zinc
group)
(control
group).
Moreover,
showed
lower
APRI
scores
than
after
a
follow-up
period,
but
there
was
non-significant
FIB-4
between
treatment.
total
bilirubin
months.
Conclusions
Administering
could
potentially
serve
safe
efficient
therapeutic
strategy
management
hepatic
individuals
hepatitis
virus.
Trial
Registration
ClinicalTrials.gov
identifier:
NCT05465434,
On
19/7/2022.
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Янв. 31, 2025
Cirrhotic
portal
hypertension,
the
most
prevalent
and
clinically
significant
complication
of
liver
cirrhosis,
manifests
as
elevated
venous
pressure
is
associated
with
severe
complications.
Although
much
research
on
mechanisms
hypertension
has
focused
fibrosis,
less
attention
been
given
to
role
intrahepatic
extrahepatic
vascular
dysfunction,
particularly
respect
vasculature.
While
hepatic
fibrosis
in
cirrhotic
undeniable,
underlying
involving
vasculature
are
highly
complex.
Sinusoidal
capillarization
endothelial
dysfunction
contribute
increased
resistance.
Hemodynamic
changes
circulation,
including
splanchnic
vasodilation
hyperdynamic
play
a
development
hypertension.
Additionally,
therapeutic
strategies
targeting
these
diverse,
improvement
sinusoidal
microcirculation,
therapies
stellate
cells
activation,
pharmacological
modulation
systemic
tone.
Therefore,
this
review,
we
will
discuss
vascular-related
treatment
progress
cirrhosis
provide
new
theoretical
basis
practical
guidance
for
clinical
treatment.
Pharmaceuticals,
Год журнала:
2025,
Номер
18(2), С. 227 - 227
Опубликована: Фев. 7, 2025
Background:
Liver
fibrosis
is
a
prevalent,
chronic
inflammatory
condition
characterized
by
the
excessive
accumulation
of
extracellular
matrix
components
and,
primarily,
collagen
in
liver.
Huo-xue-shen
(HXS)
has
proven
effective
for
treatment
liver
fibrosis.
However,
mechanism
yet
to
be
deciphered.
Methods:
Network
pharmacology,
machine
learning
algorithms
and
RNA-seq
were
used
predict
immune-treated
targets
mechanisms
associated
with
HXS
Molecular
docking
was
employed
screen
agents
based
on
drug-compound-hub
gene
network
HXS,
aiming
identify
most
critical
bioactive
compound
Results:
A
total
100
(ITTs)
found
significantly
regulate
PI3K-Akt
signaling
pathway
MAPK
pathway.
Among
these,
CDKN1A,
NR1I3,
TUBB1,
which
can
concurrently
interact
quercetin,
prognosis
fibrosis,
indicating
that
may
inhibit
or
reverse
HSC
activation
primarily
suppressing
neutrophil
trap
formation,
stimulating
oxidative
phosphorylation
promoting
thyroid
hormone
synthesis
regulation
microenvironment.
Conclusions:
Our
study
suggests
delay
progression
targeting
multiple
pathways,
as
shown
pharmacology
transcriptome
profiling
examine
immune
environment.
Quercetin,
its
key
ingredient,
likely
plays
an
important
role
mediating
TUBB1
pathways.
Overall,
our
findings
provide
new
perspective
potential
biological
this
traditional
Chinese
medicine
formula.
Cancers,
Год журнала:
2025,
Номер
17(6), С. 953 - 953
Опубликована: Март 12, 2025
The
liver
is
the
most
common
site
of
metastasis
colorectal
cancer
(CRC),
and
one
major
causes
CRC-related
deaths
worldwide.
tumor
microenvironment,
particularly
extracellular
matrix
(ECM),
plays
a
critical
role
in
CRC
chemoresistance.
Based
on
findings
from
clinical
basic
research,
this
review
attempts
to
offer
complete
understanding
ECM
suggest
potential
ways
for
therapeutic
intervention.
First,
ECMs’
regulating
cell
fate
explored.
We
then
discuss
hepatic
fingerprint
its
influence
metastatic
behavior
cells,
highlighting
key
molecular
interactions
that
promote
metastasis.
In
addition,
we
examine
how
changes
within
niche
contribute
chemoresistance,
focusing
remodeling
by
stiffening
activation
specific
signaling
pathways.
Understanding
these
mechanisms
crucial
development
novel
strategies
overcome
improve
outcomes
patients.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 20, 2025
ETS-1,
a
key
member
of
the
Erythroblast
Transformation-Specific
(ETS)
transcription
factor
family,
plays
an
important
role
in
cell
biology
and
medical
research
due
to
its
wide
expression
profile
strong
transcriptional
regulation
ability.
It
regulates
fundamental
biological
processes,
including
proliferation,
differentiation,
apoptosis,
is
involved
tumorigenesis
metastasis,
promoting
malignant
behaviors
such
as
angiogenesis,
matrix
degradation,
migration.
Given
association
between
ETS-1
overexpression
aggressive
characteristics
multiple
malignancies,
it
represents
promising
therapeutic
target
cancer
treatment.
This
study
aims
systematically
analyze
within
tumor
immune
microenvironment,
elucidating
mechanisms
initiation,
progression,
metastasis.
also
investigates
differential
across
tissues
adjacent
normal
tissues,
exploring
potential
molecular
marker
for
diagnosis
prognosis.
Deleted Journal,
Год журнала:
2025,
Номер
unknown, С. 1 - 13
Опубликована: Апрель 10, 2025
This
review
aims
to
explore
the
research
progress
and
application
prospects
of
mesenchymal
stem
cells
(MSCs)
in
treatment
ischemic
cardiomyopathy
(ICM).
ICM
is
a
severe
heart
disease
characterized
by
death
myocardial
due
long-term
ischemia,
leading
impaired
function.
MSCs
have
become
one
promising
therapeutic
methods
for
treating
their
unique
anti-inflammatory,
anti-apoptotic,
immunomodulatory,
pro-angiogenic
properties.
Studies
shown
that
can
improve
function
promoting
neovascularization,
reducing
cell
apoptosis,
inhibiting
inflammatory
responses,
regulating
immune
reactions.
Additionally,
be
sourced
from
various
tissues,
including
bone
marrow,
adipose
tissue,
umbilical
cord/placenta,
with
different
sources
possessing
distinct
characteristics
effects.
Clinical
studies
indicated
MSC
therapy
physical
capacity
left
ventricular
ejection
fraction
(LVEF)
patients
intractable
angina,
enhance
perfusion
overall
infarction.
However,
issues
such
as
mechanisms
MSCs,
optimal
source,
infusion
routes,
dose
optimization
still
require
further
research.
Future
need
address
these
transform
clinical
trials
routine
practice,
thereby
revolutionizing
management
prognosis
ICM.
Journal of Clinical and Translational Hepatology,
Год журнала:
2024,
Номер
000(000), С. 000 - 000
Опубликована: Июнь 11, 2024
Tissue
inhibitor
of
metalloproteinase-1
(TIMP-1)
plays
a
role
in
the
excessive
generation
extracellular
matrix
liver
fibrosis.
This
study
aimed
to
explore
pathways
through
which
TIMP-1
controls
monocyte
chemoattractant
protein-1
(MCP-1)
expression
and
promotes
hepatic
macrophage
recruitment.